Trial intelligence / Profile preview

Preventive Oral Iron Supplementation in Pregnancy

ChiCTR2600122683Phase 4Not yet recruiting

Sponsor
First Affiliated Hospital of Chongqing Medical University
Start
Apr 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of iron dextran in iron deficiency anemia (IDA) (3 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoints: Incidence of iron deficiency, Incidence of iron deficiency anemia and 1 more. Planned start Apr 2026; status: not yet recruiting.

02

Drugs

iron dextran
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on ChiCTR2600122683.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600122683.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call